Leukemia Clinical Trials

Showing 4181-4200 of 8,366 trials

ctDNA as a Biomarker for Treatment in Advanced NSCLC

NCT05486988

The dynamic monitoring of circulating tumor DNA aims to evaluate the response and progression-free survival of short-course chemotherapy (2 cycles) combined with immunotherapy in patients with locally advanced unresectable or metastatic non-small cell lung cancer.

Non-small Cell Lung Cancer

Fuzhou General Hospital500 participantsStarted Jul 2022

Fuzhou, Fujian, China

WITHDRAWN

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

NCT04807478

This study will demonstrate Short-, mid-, and long-term safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source of calories and fatty acids in this patient population

Parenteral Nutrition Associated Liver DiseaseEssential Fatty Acid DeficiencyNeurocognitive Deficit+2 more

Fresenius KabiStarted Apr 2022

WITHDRAWNPhase 2

Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)

NCT04665115

This phase II trial studies the effects of ibrutinib in treating patients with B-cell malignancies who are infected with COVID-19. Ibrutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ibrutinib is a first in class Bruton tyrosine kinase inhibitor (BTKi), for the treatment of B-cell malignancies. This study is being done to determine if taking ibrutinib after contracting COVID-19 will make symptoms better or worse.

Asymptomatic COVID-19 Infection Laboratory-ConfirmedB-Cell NeoplasmChronic Lymphocytic Leukemia+6 more

Academic and Community Cancer Research UnitedStarted Nov 2020

Rochester, Minnesota, United States

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)

Related Searches

Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

Milk Desensitization in Children

Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLC

Egg Allergy Oral Desensitization

Swallowing Evaluation in VF Immobility

A Study of PLX2853 in Advanced Malignancies.

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)